Zinc sulfate 3 MG/ML Injectable Solution — RxCUI 2201521
RxNorm drug concept · Semantic clinical drug
RxCUI 2201521
Semantic clinical drug · SCD
● Current RxNorm concept 22 FDA products
22 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2201521
Official nameZinc sulfate 3 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asZnSO4 3 MG/ML Injectable Solution
FDA products mapped22
Package NDCs mapped22
Reported Medicaid activity (SDUD)17,816 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Zinc sulfate 3 MG/ML Injectable Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Zinc sulfate 3 MG/ML Injectable Solution
RxCUI 2201521 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Zinc sulfate
39954IN
-
Zinc sulfate
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Zinc sulfate Injectable Solution
2201520SCDF -
Zinc sulfate Injectable Product
1163042SCDG -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Zinc sulfate Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Zinc sulfate 3 MG/ML
2201519SCDC
-
Zinc sulfate 3 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Zinc sulfate 3 MG/ML
SCDC · 2201519 -
Zinc sulfate Injectable Solution
SCDF · 2201520 -
Zinc sulfate Injectable Product
SCDG · 1163042
📦 FDA Products & Package NDCs
22 products · 22 package NDCs
22 package NDCs map to RxCUI 2201521 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00517-6101-25 | 25 VIAL in 1 TRAY (0517-6101-25) / 10 mL in 1 VIAL (0517-61... | Zinc Sulfate | American Regent, Inc. | 2020-05-18 |
| 00517-6103-25 | 25 VIAL in 1 TRAY (0517-6103-25) / 10 mL in 1 VIAL (0517-61... | Zinc Sulfate | American Regent, Inc. | 2019-10-01 |
| 00517-8005-25 | 25 VIAL in 1 TRAY (0517-8005-25) / 5 mL in 1 VIAL (0517-800... | Zinc Sulfate | American Regent, Inc. | 2019-10-01 |
| 31722-0453-31 | 25 VIAL in 1 CARTON (31722-453-31) / 10 mL in 1 VIAL (31722... | ZINC SULFATE | Camber Pharmaceuticals, Inc. | 2025-05-01 |
| 31722-0454-31 | 25 VIAL in 1 CARTON (31722-454-31) / 10 mL in 1 VIAL (31722... | ZINC SULFATE | Camber Pharmaceuticals, Inc. | 2025-05-01 |
| 31722-0455-31 | 25 VIAL in 1 CARTON (31722-455-31) / 5 mL in 1 VIAL (31722-... | ZINC SULFATE | Camber Pharmaceuticals, Inc. | 2025-05-01 |
| 65219-0401-01 | 25 VIAL in 1 TRAY (65219-401-01) / 10 mL in 1 VIAL (65219-4... | Zinc Sulfate | Fresenius Kabi USA, LLC | 2022-12-27 |
| 65219-0403-03 | 25 VIAL in 1 TRAY (65219-403-03) / 10 mL in 1 VIAL (65219-4... | Zinc Sulfate | Fresenius Kabi USA, LLC | 2022-12-27 |
| 65219-0405-05 | 25 VIAL in 1 TRAY (65219-405-05) / 5 mL in 1 VIAL (65219-40... | Zinc Sulfate | Fresenius Kabi USA, LLC | 2022-12-27 |
| 66794-0239-42 | 25 VIAL in 1 CARTON (66794-239-42) / 5 mL in 1 VIAL (66794-... | Zinc Sulfate | Piramal Critical Care Inc. | 2022-06-20 |
| 66794-0240-42 | 25 VIAL in 1 CARTON (66794-240-42) / 10 mL in 1 VIAL (66794... | Zinc Sulfate | Piramal Critical Care Inc. | 2022-06-20 |
| 68083-0498-25 | 25 VIAL in 1 CARTON (68083-498-25) / 10 mL in 1 VIAL | Zinc Sulfate | Gland Pharma Limited | 2022-05-03 |
| 68083-0499-25 | 25 VIAL in 1 CARTON (68083-499-25) / 5 mL in 1 VIAL | Zinc Sulfate | Gland Pharma Limited | 2022-05-03 |
| 68083-0608-25 | 25 VIAL in 1 CARTON (68083-608-25) / 10 mL in 1 VIAL | Zinc Sulfate | Gland Pharma Limited | 2023-09-01 |
| 70069-0691-25 | 25 VIAL in 1 CARTON (70069-691-25) / 5 mL in 1 VIAL (70069-... | Zinc sulfate | Somerset Therapeutics, LLC | 2024-07-18 |
| 70069-0692-25 | 25 VIAL in 1 CARTON (70069-692-25) / 10 mL in 1 VIAL (70069... | Zinc sulfate | Somerset Therapeutics, LLC | 2024-07-18 |
| 70710-1876-07 | 25 VIAL in 1 CARTON (70710-1876-7) / 10 mL in 1 VIAL (70710... | zinc sulfate | Zydus Pharmaceuticals USA Inc. | 2023-12-07 |
| 70710-1877-07 | 25 VIAL in 1 CARTON (70710-1877-7) / 10 mL in 1 VIAL (70710... | zinc sulfate | Zydus Pharmaceuticals USA Inc. | 2023-12-07 |
| 70710-1878-07 | 25 VIAL in 1 CARTON (70710-1878-7) / 5 mL in 1 VIAL (70710-... | zinc sulfate | Zydus Pharmaceuticals USA Inc. | 2023-12-07 |
| 70771-1848-07 | 25 VIAL in 1 CARTON (70771-1848-7) / 10 mL in 1 VIAL (70771... | zinc sulfate | Zydus Lifesciences Limited | 2023-12-07 |
| 70771-1849-07 | 25 VIAL in 1 CARTON (70771-1849-7) / 10 mL in 1 VIAL (70771... | zinc sulfate | Zydus Lifesciences Limited | 2023-12-07 |
| 70771-1850-07 | 25 VIAL in 1 CARTON (70771-1850-7) / 5 mL in 1 VIAL (70771-... | zinc sulfate | Zydus Lifesciences Limited | 2023-12-07 |
Observed labelers:
American Regent, Inc. (3) ·
Camber Pharmaceuticals, Inc. (3) ·
Fresenius Kabi USA, LLC (3) ·
Gland Pharma Limited (3) ·
Zydus Lifesciences Limited (3) ·
Zydus Pharmaceuticals USA Inc. (3)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.